Targeting TDP‐43 proteinopathy with drugs and drug‐like small molecules
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15148
Abstract: Following the discovery of the involvement of the ribonucleoprotein TDP‐43 in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), a major research focus has been to develop treatments that can prevent or alleviate these… read more here.
Keywords: drugs drug; proteinopathy drugs; tdp; small molecules ... See more keywords